Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with XFOR: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
XFOR
X4 Pharmaceuticals, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
XFOR
X4 Pharmaceuticals, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
AMGN
4 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.7%
▲
+3.73%
×1.00
Q2 FY26
±4.1%
▲
+4.57%
×1.12
Q1 FY26
±3.9%
▼
−4.75%
×1.23
Feb 4 '26
±3.7%
▲
+8.15%
×2.22
XFOR
No earnings history for XFOR.
= implied
AMGN realized, solid
XFOR realized, hatched
One scale, both sides: full bar = 9%
× = |realized| ÷ implied
Source: market data
AMGN
Amgen Inc
Change
461.49
· pre 460.22
· delayed
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
XFOR
X4 Pharmaceuticals, Inc
Change
3.04
· pre 3.04
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$313.5M
Revenue
$3M
Q3 FY26
Revenue
$35M
FY25
vs
Compare
Pre-market
Nov 5 '26
delayed
AMGN
Amgen Inc
vs
XFOR
X4 Pharmaceuticals, Inc
461.49
pre 460.22
delayed
Price
3.04
pre 3.04
delayed
$249.0B
Mkt cap
$313.5M
Q3 FY26
$10.4B
Revenue
$3M
Q3 FY26
FY25
$36.8B
Revenue
$35M
FY25
Change
Change
AMGN
461.49
vs
XFOR
3.04
Pre-market
Nov 5 '26
delayed